Antibody responses in patients with farmer's lung disease to antigens from Micropolyspora faeni

Related Experiment Videos

Insights

Farmer's lung disease involves immune responses to Micropolyspora faeni antigens. Glycoprotein antigens trigger antibodies only in patients, suggesting a specific diagnostic marker for farmer's lung.

Area of Science:

  • Immunology
  • Microbiology
  • Pulmonary Medicine

Background:

  • Farmer's lung disease is a hypersensitivity pneumonitis.
  • It is caused by exposure to thermophilic actinomycetes, such as Micropolyspora faeni.
  • Identifying specific antigens and immune responses is crucial for diagnosis and understanding pathogenesis.

Purpose of the Study:

  • To isolate and characterize antigens from Micropolyspora faeni.
  • To investigate the antibody responses to these antigens in farmer's lung disease patients and healthy farmers.
  • To elucidate the immunological mechanisms involved in farmer's lung disease.

Main Methods:

  • Extraction of glycoprotein and protein antigens from Micropolyspora faeni mycelium using phenol or trichloroacetic acid.
  • Purification and characterization of antigens using immunoelectrophoresis.
  • Analysis of patient and farmer sera for antibodies using precipitins and latex agglutination tests.
  • Fractionation of immunoglobulins (IgG, IgA, IgM).

Main Results:

  • Three purified glycoprotein antigens (a, b, c) and protein antigens were extracted.
  • Antibodies to glycoprotein antigens were specific to farmer's lung disease patients.
  • Antibodies to protein antigens were found in both patients and asymptomatic farmers.
  • Precipitins to antigen 'a' were present in all farmer's lung disease cases.
  • Precipitins were primarily IgG, while latex-agglutinating antibodies included IgG, IgA, and IgM.

Conclusions:

  • Glycoprotein antigen 'a' is a potential diagnostic marker for farmer's lung disease.
  • Farmer's lung disease may involve a cytotoxic type II hypersensitivity reaction.
  • The reaction involves glycoproteins on cell surfaces interacting with patient immunoglobulins and complement, leading to tissue damage.

Related Concept Videos